Sangamo Therapeutics (SGMOQ) Net Shares Issued and Repurchased (2012 - 2018)

Sangamo Therapeutics has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $3.1 million in Q4 2018.

• On a quarterly basis, Net Shares Issued and Repurchased rose 0.77% year-over-year to $3.1 million in Q4 2018; TTM through Dec 2018 was $3.1 million, a 0.77% increase from a year earlier, with the FY2018 full-year figure at $3.1 million, up 0.77% from the prior year.
• Net Shares Issued and Repurchased was $3.1 million for Q4 2018 at Sangamo Therapeutics, up from $3.1 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $3.1 million in Q4 2018, with the low at $1.6 million in Q4 2015.
• Average Net Shares Issued and Repurchased over 5 years is $2.3 million, with a median of $2.0 million recorded in 2016.
• The sharpest annual moves came in 2015 and 2017: Net Shares Issued and Repurchased dropped 3.9% in 2015, then surged 54.94% in 2017.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.7 million in 2014, then declined by 3.9% to $1.6 million in 2015, then climbed by 22.51% to $2.0 million in 2016, then soared by 54.94% to $3.1 million in 2017, then gained by 0.77% to $3.1 million in 2018.
• The last three Net Shares Issued and Repurchased figures came in at $3.1 million (Q4 2018), $3.1 million (Q4 2017), and $2.0 million (Q4 2016), per Business Quant data.